Beam Therapeutics Inc (BEAM) — Capital Reinvestment Ratio
Beam Therapeutics Inc (BEAM) has a Capital Reinvestment Ratio of 0.03x as of December 2023, meaning it reinvests 0% of its operating cash flow ($135.07 Million) in capital expenditures ($3.59 Million). Check BEAM goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Beam Therapeutics Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks Beam Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Beam Therapeutics Inc (BEAM) cash flow conversion.
Annual Capital Reinvestment Ratio for Beam Therapeutics Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for Beam Therapeutics Inc from 2022 to 2022. See how much free cash does Beam Therapeutics Inc generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.17x | $22.53 Million | $48.95 Million | — |